More expensive isn't always better: NPH versus insulin analogs as initial long-acting insulin

Ben Arthur; Ashley Smith; Nick Bennett; David Bury

doi:10.1097/EBP.0000000000001140

More expensive isn't always better: NPH versus insulin analogs as initial long-acting insulin

Ben Arthur
, Ashley Smith
, Nick Bennett
, David Bury

Pediatrics

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	3-4
Number of pages	2
Journal	Evidence-Based Practice
Volume	24
Issue number	6
DOIs	https://doi.org/10.1097/EBP.0000000000001140
State	Published - 3 Jun 2021

Access to Document

10.1097/EBP.0000000000001140

Cite this

@article{f13f3967a6e54877bcfde4049a8f89cc,

title = "More expensive isn't always better: NPH versus insulin analogs as initial long-acting insulin",

author = "Ben Arthur and Ashley Smith and Nick Bennett and David Bury",

year = "2021",

month = jun,

day = "3",

doi = "10.1097/EBP.0000000000001140",

language = "English",

volume = "24",

pages = "3--4",

journal = "Evidence-Based Practice",

issn = "1095-4120",

publisher = "Lippincott Williams and Wilkins",

number = "6",

}

TY - JOUR

T1 - More expensive isn't always better

T2 - NPH versus insulin analogs as initial long-acting insulin

AU - Arthur, Ben

AU - Smith, Ashley

AU - Bennett, Nick

AU - Bury, David

PY - 2021/6/3

Y1 - 2021/6/3

UR - https://www.scopus.com/pages/publications/85158844200

U2 - 10.1097/EBP.0000000000001140

DO - 10.1097/EBP.0000000000001140

M3 - Comment/debate

AN - SCOPUS:85158844200

SN - 1095-4120

VL - 24

SP - 3

EP - 4

JO - Evidence-Based Practice

JF - Evidence-Based Practice

IS - 6

ER -

More expensive isn't always better: NPH versus insulin analogs as initial long-acting insulin

Access to Document

Fingerprint

Cite this